James Edward Doyle - Oct 9, 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ James Edward Doyle by Mark Busch, attorney-in- fact
Stock symbol
EXAS
Transactions as of
Oct 9, 2025
Transactions value $
-$120,000
Form type
4
Date filed
10/10/2025, 05:25 PM
Previous filing
Aug 14, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle James Edward Director EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON /s/ James Edward Doyle by Mark Busch, attorney-in- fact 2025-10-10 0001614265

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Sale -$120K -2K -3.34% $60.00 58K Oct 9, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2025.